Galera Therapeutics
Presença
Galera Therapeutics é uma empresa listada sob o símbolo GRTX (US).
Executivos
Veja o organograma con seus 12 executivos principais
Biografias mais buscadas da Galera Therapeutics
- Mel Sorensen, Director, President and Chief Executive Officer
- Linda West, Director
- Mike Powell, Chairman of the Board
Recentes movimentos de executivos em Galera Therapeutics
- Mark Bachleda, Chief Commercial Officer, deixou a Companhia (Notícia publicada em 18 de agosto de 2023).
Criar um alerta
para seguir os movimentos de executivos da Galera Therapeutics.
Biotecnologia
Galera Therapeutics possui 2.280 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Metsera acaba de anunciar uma arrecadação de fundos de 290 milhões de dólares. (publicado em 23 de abril de 2024).
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado em 18 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Galera Therapeutics
- Galera Therapeutics to Host Virtual KOL Event on the Treatment of Locally Advanced Pancreatic Cancer | Galera Therapeutics
- Galera Therapeutics Announces Dosing of First Patient in a Randomized, Double-Blind Pilot Phase 2 Clinical Trial of GC4419 for COVID-19 | Galera Therapeutics
- Galera Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit | Galera Therapeutics
- Galera Therapeutics Announces ASTRO Late-Breaker Presentation of Topline Safety and Efficacy Data from its Double-Blind, Placebo-Controlled Phase 1b/2a Clinical Trial of GC4419 in Combination with SBRT for Locally Advanced Pancreatic Cancer | Galera Thera
- Galera Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates | Galera Therapeutics
- News Releases | Galera Therapeutics
- Galera Therapeutics to Participate in Fireside Chat at 2020 BTIG Virtual Biotechnology Conference | Galera Therapeutics
- Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally Advanced Pancreatic Cancer | Galera Therapeutics
- Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin | Galera Therapeutics
- Galera Therapeutics to Host Virtual KOL Event on Cisplatin-Induced Chronic Kidney Disease | Galera Therapeutics
- View more press releases Close
Redes sociais sobre Galera Therapeutics
- Galera Therapeutics na Wikipedia, Google News e Yahoo Finance
- Galera Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Mel Sorensen 
Ligue para a Galera Therapeutics em +1 610...
